# Assessing Neurodevelopment in Congenital Heart Disease.

> **NCT02996630** · NA · UNKNOWN · sponsor: **Hospital Universitari Vall d'Hebron Research Institute** · enrollment: 250 (estimated)

## Conditions studied

- Congenital Heart Disease

## Interventions

- **PROCEDURE:** Sonography
- **DEVICE:** Magnetic Resonance Imaging
- **OTHER:** Bailey Test
- **PROCEDURE:** Surgical intervention
- **PROCEDURE:** Brain monitoring
- **PROCEDURE:** cord blood sample

## Key facts

- **NCT ID:** NCT02996630
- **Lead sponsor:** Hospital Universitari Vall d'Hebron Research Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-05
- **Primary completion:** 2017-05
- **Final completion:** 2018-05
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2016-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02996630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02996630, "Assessing Neurodevelopment in Congenital Heart Disease.". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02996630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*